Cargando…

Pharmacokinetic studies in children: recommendations for practice and research

Optimising the dosing of medicines for neonates and children remains a challenge. The importance of pharmacokinetic (PK) and pharmacodynamic (PD) research is recognised both in medicines regulation and paediatric clinical pharmacology, yet there remain barriers to undertaking high-quality PK and PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barker, Charlotte I S, Standing, Joseph F, Kelly, Lauren E, Hanly Faught, Lauren, Needham, Allison C, Rieder, Michael J, de Wildt, Saskia N, Offringa, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Drug Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047150/ https://www.ncbi.nlm.nih.gov/pubmed/29674514 http://dx.doi.org/10.1136/archdischild-2017-314506

Ejemplares similares

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis
por: Ruslami, Rovina, et al.
Publicado: (2022)

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Safety of new medicines in young children
por: Choonara, Imti
Publicado: (2011)

Inter-individual variation in midazolam clearance in children
por: Altamimi, Mohammed I, et al.
Publicado: (2015)

Acceptability of different oral formulations in infants and preschool children
por: van Riet-Nales, Diana A, et al.
Publicado: (2013)

Systematic review of the toxicity of short-course oral corticosteroids in children
por: Aljebab, Fahad, et al.
Publicado: (2016)

Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
por: van Riet-Nales, Diana A, et al.
Publicado: (2016)

Drug use and upper gastrointestinal complications in children: a case–control study
por: Bianciotto, Manuela, et al.
Publicado: (2013)

Lack of a significant change in caffeine metabolism in underweight children as determined by the caffeine breath test
por: Oshikoya, K A, et al.
Publicado: (2015)

Observational study on the palatability and tolerability of oral prednisolone and oral dexamethasone in children in Saudi Arabia and the UK
por: Aljebab, Fahad, et al.
Publicado: (2018)

Ciprofloxacin safety in paediatrics: a systematic review
por: Adefurin, Abiodun, et al.
Publicado: (2011)

Drug treatment of inborn errors of metabolism: a systematic review
por: Alfadhel, Majid, et al.
Publicado: (2013)

Rational prescribing is important in all settings
por: Choonara, Imti
Publicado: (2013)

Paediatric clinical pharmacology in the UK
por: Choonara, Imti, et al.
Publicado: (2014)

How safe is paracetamol?
por: Star, Kristina, et al.
Publicado: (2015)

Biosimilar infliximab use in paediatric IBD
por: Richmond, Lisa, et al.
Publicado: (2018)

Predictors of intravenous amiodarone induced liver injury
por: Diab, O.A., et al.
Publicado: (2017)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy
por: Belleudi, Valeria, et al.
Publicado: (2018)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Safety of ceftriaxone in paediatrics: a systematic review
por: Zeng, Linan, et al.
Publicado: (2020)

Can parents believe websites’ information about methylphenidate’s side effects?
por: Arsac England, Tom, et al.
Publicado: (2021)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Useful pharmacodynamic endpoints in children: selection, measurement, and next steps
por: Kelly, Lauren E, et al.
Publicado: (2018)

Anti-VEGF treatment for acute ROP – not yet recommended!
por: Gilbert, Clare
Publicado: (2014)

Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes
por: Svehlikova, Eva, et al.
Publicado: (2021)

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
por: Nagasu, Hajime, et al.
Publicado: (2021)

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
por: Berger, Thomas, et al.
Publicado: (2016)

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function
por: Moore, Kenneth T, et al.
Publicado: (2014)

Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir
por: Johnson, Mark, et al.
Publicado: (2014)

Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing
por: Swainson, Jennifer, et al.
Publicado: (2022)

Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
por: Agarwalla, Anjali, et al.
Publicado: (2022)

Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors
por: Castle, Jessica R., et al.
Publicado: (2018)

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
por: Rosenstock, Julio, et al.
Publicado: (2020)

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge
por: Stefanovski, Darko, et al.
Publicado: (2022)

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA(1c) and Insulin Use: An Analysis From the FIDELIO-DKD Study
por: Rossing, Peter, et al.
Publicado: (2022)

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial
por: Danne, Thomas, et al.
Publicado: (2020)

Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis
por: Bentley, Siân, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children
por: Boonsathorn, Sophida, et al.
Publicado: (2018)

Tenofovir induced Fanconi syndrome: A possible pharmacokinetic interaction
por: Kapadia, Jigar, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_db1532tvd9pi2issk1ki6f2f5h